Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CAPTURE study

Fig. 2

Use of glucose lowering drugs stratified by medication class and CVD subtype in Mexico. ASCVD: atherosclerotic cardiovascular disease; CVD: cardiovascular disease; DPP-4: dipeptidyl peptidase 4; GLP-1RA: glucagon-like peptide-1 receptor agonist; OAD: oral anti-diabetic drug; SGLT2i: sodium-glucose co-transporter-2 inhibitor; SU: sulphonylureas; TZD: thiazolidinediones. Population at risk was defined according to REWIND and DECLARE-TIMI 58 criteria [10, 14]

Back to article page